BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29670091)

  • 1. Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus.
    Liang J; Guo L; Li K; Xiao X; Zhu W; Zheng X; Hu J; Zhang H; Cai J; Yu Y; Tan Y; Li C; Liu X; Hu C; Liu Y; Qiu P; Su X; He S; Lin Y; Yan G
    Nat Commun; 2018 Apr; 9(1):1524. PubMed ID: 29670091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1.
    Cai J; Lin K; Cai W; Lin Y; Liu X; Guo L; Zhang J; Xu W; Lin Z; Wong CW; Sander M; Hu J; Yan G; Zhu W; Liang J
    Mol Oncol; 2020 Dec; 14(12):3153-3168. PubMed ID: 33037696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
    Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of CCDC6 sensitizes tumor to oncolytic virus M1.
    Liu Y; Li K; Zhu WB; Zhang H; Huang WT; Liu XC; Lin Y; Cai J; Yan GM; Qiu JG; Peng L; Liang JK; Hu C
    Neoplasia; 2021 Jan; 23(1):158-168. PubMed ID: 33338804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.
    Li K; Liang J; Lin Y; Zhang H; Xiao X; Tan Y; Cai J; Zhu W; Xing F; Hu J; Yan G
    Oncotarget; 2016 Jul; 7(30):48443-48455. PubMed ID: 27374176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
    Tan Y; Lin Y; Li K; Xiao X; Liang J; Cai J; Guo L; Li C; Zhu W; Xing F; Mai J; Gu J; Tan X; Yin W; Lu B; Qiu P; Su X; Gao M; Hu J; He S; Lu L; Gong S; Yan G; Zhang H
    Hum Gene Ther; 2018 Aug; 29(8):950-961. PubMed ID: 28750564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
    Xiao X; Liang J; Huang C; Li K; Xing F; Zhu W; Lin Z; Xu W; Wu G; Zhang J; Lin X; Tan Y; Cai J; Hu J; Chen X; Huang Y; Qin Z; Qiu P; Su X; Chen L; Lin Y; Zhang H; Yan G
    Nat Commun; 2018 Oct; 9(1):4342. PubMed ID: 30337542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics.
    Cai J; Lin Y; Zhang H; Liang J; Tan Y; Cavenee WK; Yan G
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6812-6817. PubMed ID: 28607091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.
    Li K; Zhang H; Qiu J; Lin Y; Liang J; Xiao X; Fu L; Wang F; Cai J; Tan Y; Zhu W; Yin W; Lu B; Xing F; Tang L; Yan M; Mai J; Li Y; Chen W; Qiu P; Su X; Gao G; Tai PW; Hu J; Yan G
    Mol Ther; 2016 Feb; 24(1):156-65. PubMed ID: 26373347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome Encapsulation of Oncolytic Virus M1 To Reduce Immunogenicity and Immune Clearance in Vivo.
    Wang Y; Huang H; Zou H; Tian X; Hu J; Qiu P; Hu H; Yan G
    Mol Pharm; 2019 Feb; 16(2):779-785. PubMed ID: 30604617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.
    Lin Y; Zhang H; Liang J; Li K; Zhu W; Fu L; Wang F; Zheng X; Shi H; Wu S; Xiao X; Chen L; Tang L; Yan M; Yang X; Tan Y; Qiu P; Huang Y; Yin W; Su X; Hu H; Hu J; Yan G
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4504-12. PubMed ID: 25288727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
    Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
    Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
    Hu C; Liu Y; Lin Y; Liang JK; Zhong WW; Li K; Huang WT; Wang DJ; Yan GM; Zhu WB; Qiu JG; Gao X
    Cell Death Dis; 2018 Feb; 9(3):274. PubMed ID: 29449555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
    Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
    Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
    Zheng JN; Pei DS; Mao LJ; Liu XY; Mei DD; Zhang BF; Shi Z; Wen RM; Sun XQ
    Cancer Gene Ther; 2009 Jan; 16(1):20-32. PubMed ID: 18690204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mevalonate Pathway Regulates Cell Size Homeostasis and Proteostasis through Autophagy.
    Miettinen TP; Björklund M
    Cell Rep; 2015 Dec; 13(11):2610-2620. PubMed ID: 26686643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
    Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
    Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-content assay to study protein prenylation.
    Simonen M; Ibig-Rehm Y; Hofmann G; Zimmermann J; Albrecht G; Magnier M; Heidinger V; Gabriel D
    J Biomol Screen; 2008 Jul; 13(6):456-67. PubMed ID: 18509097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-based rational design of an oncolytic virus with improved therapeutic potential.
    Le Bœuf F; Batenchuk C; Vähä-Koskela M; Breton S; Roy D; Lemay C; Cox J; Abdelbary H; Falls T; Waghray G; Atkins H; Stojdl D; Diallo JS; Kærn M; Bell JC
    Nat Commun; 2013; 4():1974. PubMed ID: 23764612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.